metaEvidence - overview


			deaths (OS)	progression or deaths (PFS)	RFS/DFS
ovarian cancer (OC) ovarian cancer (OC)
versus Standard of Care (SoC)
	niraparib vs. Standard of Care (SoC)	1	-		-
	olaparib vs. Standard of Care (SoC)	5			-
	rucaparib vs. Standard of Care (SoC)	2			-
mOC - L1 - all population metastatic/advanced OC (mOC) - 1st line (L1) mOC - L1 - all population
mOC - L1 - PDL1 positive metastatic/advanced OC (mOC) - 1st line (L1) mOC - L1 - PDL1 positive
metastatic/advanced OC (mOC) - 2nd line (L2) metastatic/advanced OC (mOC) - 2nd line (L2)
metastatic/advanced OC (mOC) - maintenance (M) metastatic/advanced OC (mOC) - maintenance (M)